Lc3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
MAP1LC3A (Microtubule-Associated Protein 1 Light Chain 3 Alpha) [@johansen2009]
This page provides comprehensive information about the institution/research center, its research programs, and contributions to neurodegenerative disease research.
Structure
...
LC3 Protein
Introduction
Lc3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
MAP1LC3A (Microtubule-Associated Protein 1 Light Chain 3 Alpha) [@johansen2009]
This page provides comprehensive information about the institution/research center, its research programs, and contributions to neurodegenerative disease research.
Structure
LC3 (MAP1LC3A) is a ubiquitin-like protein that undergoes post-translational processing:
Pro-LC3: Full-length protein synthesized in the cytoplasm
LC3-I: Cytosolic form after cleavage by ATG4
LC3-II: Lipidated form (conjugated to phosphatidylethanolamine) that associates with autophagosome membranes
The protein contains an LC3-interacting region (LIR) that allows binding to autophagy receptors containing LIR motifs.
Normal Function
LC3 is essential for autophagosome formation and function:
Autophagosome biogenesis: LC3-II is incorporated into the growing autophagosome membrane
Cargo recognition: LC3 binds to autophagy receptors (p62, NDP52, OPTN) that recognize ubiquitinated cargo
Selective autophagy: Facilitates selective degradation of damaged organelles, protein aggregates, and intracellular pathogens
Membrane fusion: Involved in autophagosome-lysosome fusion
LC3 exists in multiple isoforms (LC3A, LC3B, LC3C) with slightly different functions and tissue distributions.
Role in Disease
Alzheimer's Disease
LC3-positive autophagic vacuoles accumulate in AD brains
Impaired autophagic flux in [neurons](/entities/neurons)
Reduced clearance of [Aβ](/proteins/amyloid-beta) and [tau](/proteins/tau) aggregates
Dysregulated autophagy contributes to synaptic loss
Parkinson's Disease
LC3 is a key player in mitophagy
Impaired LC3-mediated clearance of damaged mitochondria
Klionsky DJ, et al. (2021). Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 17(1):1-382.
Johansen T, et al. (2009). p62/SQSTM1 is a target gene for transcription factor NRF2. Molecular Cell. 34(2):149-159.
Mizushima N, et al. (2008). LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes. Journal of Cell Biology. 151(3):673-680.
LC3 in Neurodegenerative Diseases
Alzheimer's Disease
LC3-mediated autophagy in AD:
Impaired autophagic flux in AD neurons
LC3 accumulation in amyloid plaques and neurofibrillary tangles
Defective clearance of [Aβ](/proteins/amyloid-beta) through autophagy
LC3-II levels elevated in AD brain tissue
Parkinson's Disease
LC3 and PD pathogenesis:
Critical for mitophagy of damaged mitochondria
Impaired clearance of [α-synuclein](/proteins/alpha-synuclein) aggregates via autophagy
The study of Lc3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.